Tet2 loss and enhanced ciliogenesis suppress α-synuclein pathology

Emmanuel Quansah1,2, Naman Vatsa3, Elizabeth Ensink3

  • 1Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, USA. quansah3@msu.edu.

Insights

Tet2 loss in Parkinson's disease (PD) models enhances primary cilia and sonic hedgehog signaling. This pathway modulation reduces alpha-synuclein pathology and dopamine neuron degeneration, offering new therapeutic targets for PD.

Area of Science:

  • Neuroscience
  • Epigenetics
  • Cell Biology

Background:

  • Parkinson's disease (PD) lacks treatments to slow progression.
  • Tet2 epigenetic marker loss shows potential benefits in PD models, but mechanisms are unclear.

Purpose of the Study:

  • Identify novel pathogenic mechanisms in PD.
  • Investigate the role of Tet2 and primary cilia in PD progression.

Main Methods:

  • Unbiased transcriptomic analysis of cortical neurons from PD patients.
  • In vitro experiments enhancing ciliogenesis via sonic hedgehog signaling.
  • In vivo studies involving Tet2 deletion in mice.

Main Results:

  • Primary cilia and sonic hedgehog signaling genes are upregulated in PD patients.
  • Enhanced ciliogenesis suppressed alpha-synuclein pathology in vitro.
  • Tet2 deletion in mice reduced alpha-synuclein pathology and dopamine neuron degeneration.

Conclusions:

  • Tet2 loss is crucial in regulating ciliogenesis.
  • Ciliogenesis and sonic hedgehog signaling are implicated in PD pathology progression.